Bipolar disorder clinical trials

Explore recruiting bipolar disorder clinical trials.

Recruiting bipolar disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bipolar disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AMIND - AMIloride for the treatment of Nephrogenic Diabetes insipidus for patients with bipolar disorder treated with lithium: a randomized controlled trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

EFFECTIVENESS OF SUPPLEMENTATION WITH VITAMIN D IN PATIENTS WITH DEPRESSIVE DISORDER OR BIPOLAR DISORDER: A RANDOMIZED CONTROLLED CLINICAL TRIAL

Italy

Phase III and phase IV (Integrated) EU CTIS Study details

Efficacy and safety of memantine as antimanic and mood-stabilizing medication for adolescents with Bipolar Disorder: a monocentric, randomized, double-blind, placebo-controlled clinical trial.

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients with Manic Episodes or Manic Episodes with Mixed Features Associated with Bipolar I Disorder (Bipolar Mania)

Bulgaria, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Melatonin versus placebo for bipolar disorder - a double blinded randomised controlled trial (The M-bipolar RCT)

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Lamotrigine Dispersible Tablets BP 100 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Lamictal (Lamotrigine) Dispersible Tablets 100 mg, Manufactured by: Delpharm Poznaÿ – Poland & Registered and Imported by: GlaxoSmithKline Brasil Ltda, in healthy adult, human subjects under fasting condition.

Romania

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Bipolar disorder trials by city

Bipolar disorder in Toronto Bipolar disorder in Vancouver Bipolar disorder in Montreal Bipolar disorder in Calgary Bipolar disorder in Edmonton Bipolar disorder in Ottawa Bipolar disorder in Winnipeg Bipolar disorder in Quebec City Bipolar disorder in Hamilton Bipolar disorder in Kitchener Bipolar disorder in London Bipolar disorder in Halifax Bipolar disorder in New York Bipolar disorder in Los Angeles Bipolar disorder in Chicago Bipolar disorder in Houston

Other conditions

Alzheimer's disease Parkinson's disease Multiple sclerosis Epilepsy ALS Huntington's disease Peripheral neuropathy Restless legs syndrome Essential tremor Dementia Depression Anxiety Schizophrenia PTSD OCD ADHD Insomnia Postpartum depression Alcohol use disorder Substance use disorder COPD Asthma Long COVID Cystic fibrosis